| bFGF | Basic fibroblast growth factor |
| BMDC | Bone marrow-derived cells |
| ECM | Extracellular matrix |
| EGF | Epidermal growth factor |
| EMT | Epithelial-to-mesenchymal transition |
| ER | Extracellular signal-regulated kinase |
| ETV | ETS variant transcription factor 4 |
| FAK | Focal adhesion kinase |
| FHRE | Forkhead response element |
| FGF | Fibroblast growth factors |
| GOLM1 | Golgi membrane protein 1 |
| HIF | Hypoxia-inducible transcription factor |
| HNSCC | Squamous cell carcinoma of the head and neck |
| IL | Interleukin |
| IFN-γ | Interferon gamma |
| ING2 | Inhibitor of growth 2 |
| IGF | Insulin-like growth factor |
| IFN-β | Interferon β |
| LOX | Lysl Oxidase |
| MMP | Matrix metalloproteinase |
| NF-κB | Nuclear factor kappa B |
| MM | Multiple Myeloma |
| OSE-2 | Osteoblast-specific element |
| PDGF | Platelet-derived growth factor |
| PTHrP | parathyroid hormone-related protein |
| PKC | Protein kinase C |
| SH | Zinc-interacting thiol |
| SUMO | Small ubiquitin related modifier |
| SENP2 | SUMO-specific protease 2 |
| TGF-β | Transforming growth factor-β1 |
| TIMPs | Tissue inhibitors of MMPs |
| TIE | Transforming growth factor-beta inhibitory element |
| TNF-α | Tumour necrosis factor alpha |
| VEGF | Vascular endothelial growth factor |